Skip to Content


In the US, Fludarabine (fludarabine systemic) is a member of the drug class antimetabolites and is used to treat Cancer, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Leukemia, Non-Hodgkin's Lymphoma and Stem Cell Transplant Conditioning.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Cytostatic agent: Antimetabolite

Chemical Name


Foreign Names

  • Fludarabinum (Latin)
  • Fludarabin (German)
  • Fludarabine (French)
  • Fludarabina (Spanish)

Generic Names

  • 2-FLAA (IS)
  • 2-Fluoroara A (IS)
  • 2-Fluoro-ara-A Monophosphate (IS)
  • FAMP (IS)
  • F-ARA-A (IS)
  • Fluorovidarabine (IS)
  • Fludarabine Phosphate (OS: BAN, USAN, JAN)
  • NSC 312887 (IS)
  • Fludarabine Phosphate (PH: BP 2016, USP 38)
  • Fludarabine phosphate (PH: Ph. Eur. 8)
  • Fludarabini phosphas (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.